A 52‐week prophylactic randomised control trial of omega‐3 polyunsaturated fatty acids in bipolar disorder-Reference-Cited by-同舟云学术

A 52‐week prophylactic randomised control trial of omega‐3 polyunsaturated fatty acids in bipolar disorder

Published:2021-01-10 Issue:7 Volume:23 Page:697-706
ISSN:1398-5647
Container-title:Bipolar Disorders
language:en
Short-container-title:Bipolar Disord

Author:

McPhilemy Genevieve¹²^ORCID,Byrne Fintan¹,Waldron Mairead²,Hibbeln Joseph R.³,Davis John⁴,McDonald Colm¹²,Hallahan Brian¹²

Affiliation:

1. The Centre for Neuroimaging & Cognitive Genomics (NICOG) Clinical Neuroimaging Lab NCBES Galway Neuroscience CentreCollege of Medicine, Nursing, and Health SciencesNational University of Ireland Galway Galway Ireland Republic of Ireland

2. Health Research Board ‐ Clinical Research Facility Galway National University of Ireland Galway and University Hospital Galway Galway Ireland

3. Section on Nutritional Neurosciences Laboratory of Membrane Biochemistry and Biophysics National Institute on Alcohol Abuse and AlcoholismNational Institutes of Health Rockville MD USA

4. Department of Psychiatry University of Illinois Chicago USA

Funder

Stanley Medical Research Institute

Publisher

Wiley

Subject

Biological Psychiatry,Psychiatry and Mental health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bdi.13037

Reference21 articles.

1. Diagnostic and Statistical Manual of Mental Disorders

2. EPA but Not DHA Appears To Be Responsible for the Efficacy of Omega-3 Long Chain Polyunsaturated Fatty Acid Supplementation in Depression: Evidence from a Meta-Analysis of Randomized Controlled Trials